High Sensitivity and Specificity Assay for Detection of Leukemia/Lymphoma Cells in Human Bone Marrow a

An assay of high sensitivity and specificity for detection of residual malignant cells in remission bone marrow from patients with acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma (NHL) has been developed. The assay combines an immunoselection step with immunoglobulin gene rearrangement analysis by high specific-activity DNA probes. In experimental conditions, less than one contaminating tumor cell out of 1000 bone marrow cells was detected. A bone marrow contamination was detected in morphologically negative bone marrow specimens from two intermediate-grade non-Hodgkin's lymphoma patients. This method can be of value in determining a true remission status in high-risk ALL and NHL patients.

[1]  Z. Estrov,et al.  Detection of residual acute lymphoblastic leukemia cells in cultures of bone marrow obtained during remission. , 1986, The New England journal of medicine.

[2]  B. Vogelstein,et al.  Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. , 1986, The New England journal of medicine.

[3]  K. Foon,et al.  Immunologic classification of leukemia and lymphoma. , 1986, Blood.

[4]  B. Vogelstein,et al.  Immunoglobulin gene rearrangements in remission bone marrow specimens from patients with acute lymphoblastic leukemia. , 1986, Blood.

[5]  P. Pelicci,et al.  T-cell receptor gene rearrangements as markers of lineage and clonality in T-cell neoplasms. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Hagenbeek,et al.  Detection of minimal residual disease in acute leukemia: possibilities and limitations. , 1985, European journal of cancer & clinical oncology.

[7]  K. Bauer,et al.  Improved detection of rare CALLA-positive cells in peripheral blood using multiparameter flow cytometry. , 1984, Journal of immunological methods.

[8]  J. Griffin,et al.  A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. , 1984, Leukemia research.

[9]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[10]  T. Waldmann,et al.  Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. , 1983, The New England journal of medicine.

[11]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[12]  T. Waldmann,et al.  Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. , 1983, The Journal of clinical investigation.

[13]  J. Ritz,et al.  Expression of MY7 antigen on myeloid precursor cells. , 1983, International journal of cell cloning.

[14]  I. Magrath,et al.  Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type. , 1982, Journal of immunology.

[15]  Ulrich Siebenlist,et al.  Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes , 1981, Cell.

[16]  J. Ritz,et al.  Expression of myeloid differentiation antigens on normal and malignant myeloid cells. , 1981, The Journal of clinical investigation.

[17]  L. Nadler,et al.  Antigens on human monocytes identified by monoclonal antibodies. , 1981, Journal of immunology.

[18]  P. Edwards,et al.  Expression of cell-surface HLA-DR, HLA-ABC and glycophorin during erythroid differentiation , 1981, Nature.

[19]  P Berg,et al.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. , 1977, Journal of molecular biology.